{"gene":"PRAP1","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2020,"finding":"PRAP1 is a novel lipid-binding protein that directly binds triglyceride (TG) and facilitates MTTP-mediated lipid transfer. PRAP1 and MTTP are partially colocalized in the endoplasmic reticulum. A single amino acid mutation at position 85 (E85V) impairs PRAP1's ability to form a ternary complex with TG and MTTP, and impairs apoB-containing lipoprotein assembly and secretion, demonstrating that ternary complex formation is required for PRAP1 to facilitate MTTP-mediated lipid transport. PRAP1 is detectable in chylomicron/VLDL-rich plasma fractions, suggesting MTTP transfers TG along with PRAP1 to lipid acceptors.","method":"Co-localization (ER fractionation), in vitro lipid-binding assay, site-directed mutagenesis (E85V), lipoprotein secretion assay, PRAP1-deficient and E85V knock-in mouse models","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of ternary complex, mutagenesis, KO mouse phenotype, multiple orthogonal methods in single study","pmids":["33168624"],"is_preprint":false},{"year":2012,"finding":"PRAP1 is a novel p53 target gene. Under DNA damage conditions (chemotherapeutic drugs, gamma irradiation, hydrogen peroxide), p53 upregulates PRAP1 expression via functional p53-response elements within intron 1 of the PRAP1 gene, which directly interact with p53 as shown by ChIP assays. PRAP1 induction promotes resistance to apoptosis by inducing cell-cycle arrest, contributing to cancer cell survival after DNA-damaging treatment.","method":"ChIP assay (p53 binding to PRAP1 intron 1), siRNA knockdown of PRAP1, cell viability and apoptosis assays after chemotherapeutic drug treatment, gamma irradiation, and hydrogen peroxide","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct p53-PRAP1 gene interaction, confirmed with KD functional readout across multiple DNA-damage stimuli","pmids":["23235459"],"is_preprint":false},{"year":2020,"finding":"PRAP1 is an intrinsically disordered 17-kDa protein highly expressed in small intestinal epithelium. Prap1-/- mice show accelerated death with significantly increased apoptosis and p21 expression in the small intestinal epithelium after total body irradiation, indicating PRAP1 protects the gastrointestinal epithelium from irradiation-induced apoptosis.","method":"Prap1-/- mouse generation and challenge with total body irradiation; measurement of apoptosis and p21 expression; enteroid ex vivo irradiation model; biochemical characterization of recombinant PRAP1","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined apoptotic phenotype, supported by ex vivo enteroid model and biochemical characterization","pmids":["32629119"],"is_preprint":false},{"year":2010,"finding":"PRAP1 (proline-rich acidic protein 1) mRNA is highly and specifically expressed in the uterine luminal epithelium. Its expression is regulated by progesterone (P) and estrogen (E2): P down-regulates Prap1, E2 transiently down-regulates it at 6 hours but dramatically induces it at 3 days. Prap1 expression disappears in preimplantation uterus and reappears in luminal epithelium after embryo implantation or artificial decidualization.","method":"mRNA expression analysis in ovariectomized mouse uterus with hormone treatments; temporal expression profiling across peri-implantation period","journal":"Fertility and sterility","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization and hormone-regulation experiment but functional link not directly demonstrated mechanistically","pmids":["20674898"],"is_preprint":false}],"current_model":"PRAP1 is a p53-target, intrinsically disordered protein that (1) acts as a lipid-binding co-factor in the endoplasmic reticulum, forming a ternary complex with triglyceride and MTTP to facilitate apoB-containing lipoprotein assembly and secretion; (2) is transcriptionally induced by p53 via direct binding to response elements in PRAP1 intron 1, where it promotes cell survival after DNA damage by inducing cell-cycle arrest; and (3) protects the gastrointestinal epithelial barrier from apoptosis following oxidative/radiation injury, as demonstrated by accelerated intestinal apoptosis and lethality in Prap1-/- mice."},"narrative":{"teleology":[{"year":2010,"claim":"Establishing tissue context: PRAP1 was shown to be highly and specifically expressed in uterine luminal epithelium under hormonal regulation, placing it as an epithelium-enriched, hormonally responsive gene whose function was otherwise unknown.","evidence":"mRNA expression profiling in ovariectomized mouse uterus with progesterone and estrogen treatments","pmids":["20674898"],"confidence":"Medium","gaps":["No functional consequence of PRAP1 loss or gain in the uterus was demonstrated","Mechanism by which steroid hormones regulate PRAP1 transcription was not defined","No protein-level validation of PRAP1 expression dynamics"]},{"year":2012,"claim":"Identifying the transcriptional regulator and cytoprotective role: p53 was shown to directly bind response elements in PRAP1 intron 1 and upregulate PRAP1 upon DNA damage, and PRAP1 knockdown revealed that the protein promotes cell survival by favoring cell-cycle arrest over apoptosis.","evidence":"ChIP assay for p53 occupancy at PRAP1 intron 1; siRNA knockdown with apoptosis and viability assays after chemotherapeutics, gamma irradiation, and H₂O₂ in human cancer cell lines","pmids":["23235459"],"confidence":"High","gaps":["Molecular mechanism by which PRAP1 induces cell-cycle arrest was not identified","In vivo relevance of the cytoprotective function was not yet tested","Downstream effectors or signaling pathways linking PRAP1 to arrest versus apoptosis decision were unknown"]},{"year":2020,"claim":"In vivo validation of the cytoprotective role and structural characterization: Prap1-knockout mice demonstrated accelerated intestinal epithelial apoptosis and death after irradiation, confirming PRAP1 as a gastrointestinal barrier protector, and biochemical characterization established PRAP1 as an intrinsically disordered protein.","evidence":"Prap1-/- mouse model with total body irradiation challenge; ex vivo enteroid irradiation assay; recombinant PRAP1 biophysical characterization","pmids":["32629119"],"confidence":"High","gaps":["Direct molecular target or binding partner mediating the anti-apoptotic function in intestinal epithelium was not identified","Relationship between intrinsic disorder and function remains uncharacterized"]},{"year":2020,"claim":"Revealing a second major function — lipid transport: PRAP1 was identified as a triglyceride-binding protein that forms a ternary complex with TG and MTTP in the ER, directly facilitating apoB-containing lipoprotein assembly and secretion, as proven by the E85V mutation that disrupts ternary complex formation.","evidence":"In vitro lipid-binding assays, ER co-fractionation, site-directed mutagenesis (E85V), lipoprotein secretion assays in PRAP1-deficient and E85V knock-in mice","pmids":["33168624"],"confidence":"High","gaps":["Structural basis for how an intrinsically disordered protein binds TG and MTTP simultaneously is unknown","Whether the lipid-transport and cytoprotective functions are mechanistically linked is untested","Physiological consequences of impaired lipoprotein assembly in PRAP1-deficient mice under dietary challenge were not fully characterized"]},{"year":null,"claim":"It remains unknown how PRAP1's intrinsically disordered structure enables dual functions in lipid transport and anti-apoptotic signaling, and whether these represent independent or coordinated activities in intestinal epithelium.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model explaining how PRAP1 engages both MTTP/TG and cell-cycle arrest pathways","Direct downstream effectors of the anti-apoptotic function have not been identified","Functional relevance of PRAP1 in uterine biology remains untested beyond expression data"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0]}],"complexes":[],"partners":["MTTP","TP53"],"other_free_text":[]},"mechanistic_narrative":"PRAP1 is an intrinsically disordered, p53-target protein that functions both as a lipid-binding co-factor facilitating apoB-containing lipoprotein assembly and as a cytoprotective factor in gastrointestinal epithelium. In the endoplasmic reticulum, PRAP1 directly binds triglyceride and forms a ternary complex with MTTP; the E85V mutation disrupts this complex and impairs MTTP-mediated lipid transfer and lipoprotein secretion [PMID:33168624]. Under DNA damage, p53 induces PRAP1 transcription via response elements in PRAP1 intron 1, and PRAP1 promotes cell survival by inducing cell-cycle arrest rather than apoptosis; accordingly, Prap1-knockout mice exhibit accelerated intestinal epithelial apoptosis and lethality after total body irradiation [PMID:23235459, PMID:32629119]."},"prefetch_data":{"uniprot":{"accession":"Q96NZ9","full_name":"Proline-rich acidic protein 1","aliases":["Epididymis tissue protein Li 178","Uterine-specific proline-rich acidic protein"],"length_aa":151,"mass_kda":17.2,"function":"Lipid-binding protein which promotes lipid absorption by facilitating MTTP-mediated lipid transfer (mainly triglycerides and phospholipids) and MTTP-mediated apoB lipoprotein assembly and secretion (By similarity). Protects the gastrointestinal epithelium from irradiation-induced apoptosis (By similarity). May play an important role in maintaining normal growth homeostasis in epithelial cells (PubMed:14583459). Involved in p53/TP53-dependent cell survival after DNA damage (PubMed:23235459). May down-regulate the expression of MAD1L1 and exert a suppressive role in mitotic spindle assembly checkpoint in hepatocellular carcinomas (PubMed:24374861)","subcellular_location":"Secreted; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q96NZ9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRAP1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRAP1","total_profiled":1310},"omim":[{"mim_id":"609776","title":"PROLINE-RICH ACIDIC PROTEIN 1; PRAP1","url":"https://www.omim.org/entry/609776"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":1069.3},{"tissue":"liver","ntpm":718.1}],"url":"https://www.proteinatlas.org/search/PRAP1"},"hgnc":{"alias_symbol":["UPA"],"prev_symbol":[]},"alphafold":{"accession":"Q96NZ9","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NZ9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NZ9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NZ9-F1-predicted_aligned_error_v6.png","plddt_mean":61.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRAP1","jax_strain_url":"https://www.jax.org/strain/search?query=PRAP1"},"sequence":{"accession":"Q96NZ9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96NZ9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96NZ9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NZ9"}},"corpus_meta":[{"pmid":"18162327","id":"PMC_18162327","title":"Evolving role of uPA/uPAR system in human cancers.","date":"2007","source":"Cancer treatment reviews","url":"https://pubmed.ncbi.nlm.nih.gov/18162327","citation_count":337,"is_preprint":false},{"pmid":"9184208","id":"PMC_9184208","title":"Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9184208","citation_count":271,"is_preprint":false},{"pmid":"17334498","id":"PMC_17334498","title":"uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.","date":"2007","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/17334498","citation_count":206,"is_preprint":false},{"pmid":"19242562","id":"PMC_19242562","title":"HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.","date":"2009","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/19242562","citation_count":126,"is_preprint":false},{"pmid":"7835780","id":"PMC_7835780","title":"Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.","date":"1994","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/7835780","citation_count":125,"is_preprint":false},{"pmid":"26667094","id":"PMC_26667094","title":"The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies.","date":"2015","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/26667094","citation_count":119,"is_preprint":false},{"pmid":"16763560","id":"PMC_16763560","title":"Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16763560","citation_count":108,"is_preprint":false},{"pmid":"11404420","id":"PMC_11404420","title":"Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11404420","citation_count":106,"is_preprint":false},{"pmid":"27895783","id":"PMC_27895783","title":"Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9.","date":"2016","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/27895783","citation_count":105,"is_preprint":false},{"pmid":"9178895","id":"PMC_9178895","title":"In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9178895","citation_count":101,"is_preprint":false},{"pmid":"23076133","id":"PMC_23076133","title":"VEGF-initiated angiogenesis and the uPA/uPAR system.","date":"2012","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/23076133","citation_count":89,"is_preprint":false},{"pmid":"12545160","id":"PMC_12545160","title":"Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12545160","citation_count":89,"is_preprint":false},{"pmid":"22223849","id":"PMC_22223849","title":"DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22223849","citation_count":84,"is_preprint":false},{"pmid":"17658220","id":"PMC_17658220","title":"Targeting uPA/uPAR in prostate cancer.","date":"2007","source":"Cancer treatment reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17658220","citation_count":82,"is_preprint":false},{"pmid":"23532574","id":"PMC_23532574","title":"The apparent uPA/PAI-1 paradox in cancer: more than meets the eye.","date":"2013","source":"Seminars in thrombosis and hemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/23532574","citation_count":68,"is_preprint":false},{"pmid":"32562843","id":"PMC_32562843","title":"COVID-19 and pneumonia: a role for the uPA/uPAR system.","date":"2020","source":"Drug discovery today","url":"https://pubmed.ncbi.nlm.nih.gov/32562843","citation_count":67,"is_preprint":false},{"pmid":"22033405","id":"PMC_22033405","title":"Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22033405","citation_count":67,"is_preprint":false},{"pmid":"33420033","id":"PMC_33420033","title":"Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33420033","citation_count":65,"is_preprint":false},{"pmid":"20052287","id":"PMC_20052287","title":"Poised transcription factories prime silent uPA gene prior to activation.","date":"2010","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/20052287","citation_count":65,"is_preprint":false},{"pmid":"16267271","id":"PMC_16267271","title":"An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16267271","citation_count":65,"is_preprint":false},{"pmid":"8869102","id":"PMC_8869102","title":"Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop.","date":"1996","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/8869102","citation_count":63,"is_preprint":false},{"pmid":"9409785","id":"PMC_9409785","title":"Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9409785","citation_count":62,"is_preprint":false},{"pmid":"28130434","id":"PMC_28130434","title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.","date":"2017","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28130434","citation_count":59,"is_preprint":false},{"pmid":"19459212","id":"PMC_19459212","title":"Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.","date":"2009","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/19459212","citation_count":58,"is_preprint":false},{"pmid":"24200850","id":"PMC_24200850","title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24200850","citation_count":56,"is_preprint":false},{"pmid":"21199807","id":"PMC_21199807","title":"Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21199807","citation_count":56,"is_preprint":false},{"pmid":"17088972","id":"PMC_17088972","title":"SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.","date":"2006","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17088972","citation_count":54,"is_preprint":false},{"pmid":"12908082","id":"PMC_12908082","title":"Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.","date":"2003","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12908082","citation_count":53,"is_preprint":false},{"pmid":"16525582","id":"PMC_16525582","title":"Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.","date":"2006","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/16525582","citation_count":53,"is_preprint":false},{"pmid":"10218628","id":"PMC_10218628","title":"Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors.","date":"1999","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10218628","citation_count":52,"is_preprint":false},{"pmid":"27986809","id":"PMC_27986809","title":"Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27986809","citation_count":51,"is_preprint":false},{"pmid":"20473943","id":"PMC_20473943","title":"β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20473943","citation_count":51,"is_preprint":false},{"pmid":"28960178","id":"PMC_28960178","title":"CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation post-entry.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28960178","citation_count":50,"is_preprint":false},{"pmid":"11236827","id":"PMC_11236827","title":"Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.","date":"2001","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/11236827","citation_count":50,"is_preprint":false},{"pmid":"34933179","id":"PMC_34933179","title":"Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.","date":"2021","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/34933179","citation_count":49,"is_preprint":false},{"pmid":"24217605","id":"PMC_24217605","title":"Role of uPA/uPAR in the modulation of angiogenesis.","date":"2013","source":"Chemical immunology and allergy","url":"https://pubmed.ncbi.nlm.nih.gov/24217605","citation_count":48,"is_preprint":false},{"pmid":"36675310","id":"PMC_36675310","title":"The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36675310","citation_count":46,"is_preprint":false},{"pmid":"12657615","id":"PMC_12657615","title":"Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12657615","citation_count":44,"is_preprint":false},{"pmid":"31006168","id":"PMC_31006168","title":"Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.","date":"2019","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31006168","citation_count":43,"is_preprint":false},{"pmid":"10571409","id":"PMC_10571409","title":"Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression.","date":"1999","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10571409","citation_count":36,"is_preprint":false},{"pmid":"19112015","id":"PMC_19112015","title":"Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression.","date":"2008","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/19112015","citation_count":35,"is_preprint":false},{"pmid":"12225951","id":"PMC_12225951","title":"Dynamics of metalloproteinase-2 and -9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization.","date":"2002","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12225951","citation_count":35,"is_preprint":false},{"pmid":"9066006","id":"PMC_9066006","title":"Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.","date":"1997","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/9066006","citation_count":35,"is_preprint":false},{"pmid":"33168624","id":"PMC_33168624","title":"PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33168624","citation_count":34,"is_preprint":false},{"pmid":"26992227","id":"PMC_26992227","title":"cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26992227","citation_count":34,"is_preprint":false},{"pmid":"17681345","id":"PMC_17681345","title":"Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner.","date":"2007","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/17681345","citation_count":34,"is_preprint":false},{"pmid":"21707478","id":"PMC_21707478","title":"Structural basis for therapeutic intervention of uPA/uPAR system.","date":"2011","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/21707478","citation_count":33,"is_preprint":false},{"pmid":"30504386","id":"PMC_30504386","title":"Naringenin Attenuated Prostate Cancer Invasion via Reversal of Epithelial-to-Mesenchymal Transition and Inhibited uPA Activity.","date":"2018","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30504386","citation_count":32,"is_preprint":false},{"pmid":"14981142","id":"PMC_14981142","title":"In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue.","date":"2004","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14981142","citation_count":31,"is_preprint":false},{"pmid":"18073130","id":"PMC_18073130","title":"Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.","date":"2008","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18073130","citation_count":30,"is_preprint":false},{"pmid":"16919601","id":"PMC_16919601","title":"Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16919601","citation_count":29,"is_preprint":false},{"pmid":"23810810","id":"PMC_23810810","title":"TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.","date":"2013","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23810810","citation_count":29,"is_preprint":false},{"pmid":"17602171","id":"PMC_17602171","title":"ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.","date":"2007","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17602171","citation_count":29,"is_preprint":false},{"pmid":"12431907","id":"PMC_12431907","title":"Plasminogen directs the pleiotropic effects of uPA in liver injury and repair.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12431907","citation_count":29,"is_preprint":false},{"pmid":"23235459","id":"PMC_23235459","title":"PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/23235459","citation_count":28,"is_preprint":false},{"pmid":"12115506","id":"PMC_12115506","title":"Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12115506","citation_count":28,"is_preprint":false},{"pmid":"22496926","id":"PMC_22496926","title":"uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases.","date":"2012","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22496926","citation_count":27,"is_preprint":false},{"pmid":"21104439","id":"PMC_21104439","title":"Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21104439","citation_count":27,"is_preprint":false},{"pmid":"25671694","id":"PMC_25671694","title":"A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.","date":"2015","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25671694","citation_count":27,"is_preprint":false},{"pmid":"29890880","id":"PMC_29890880","title":"Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.","date":"2018","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29890880","citation_count":27,"is_preprint":false},{"pmid":"27502396","id":"PMC_27502396","title":"uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27502396","citation_count":27,"is_preprint":false},{"pmid":"24434139","id":"PMC_24434139","title":"TMPRSS4 induces cancer cell invasion through pro-uPA processing.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24434139","citation_count":26,"is_preprint":false},{"pmid":"16434733","id":"PMC_16434733","title":"Differential uPA expression by TGF-beta1 in gingival fibroblasts.","date":"2006","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/16434733","citation_count":26,"is_preprint":false},{"pmid":"18533186","id":"PMC_18533186","title":"uPA and PAI-1 in rectal cancer--relationship to radiotherapy and clinical outcome.","date":"2008","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/18533186","citation_count":26,"is_preprint":false},{"pmid":"21426933","id":"PMC_21426933","title":"Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21426933","citation_count":26,"is_preprint":false},{"pmid":"17098546","id":"PMC_17098546","title":"Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.","date":"2006","source":"Journal of vascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/17098546","citation_count":26,"is_preprint":false},{"pmid":"10942386","id":"PMC_10942386","title":"The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10942386","citation_count":25,"is_preprint":false},{"pmid":"26349964","id":"PMC_26349964","title":"Non-viral transfer of BDNF and uPA stimulates peripheral nerve regeneration.","date":"2015","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/26349964","citation_count":24,"is_preprint":false},{"pmid":"24481918","id":"PMC_24481918","title":"uPA-uPAR molecular complex is involved in cell signaling during neuronal migration and neuritogenesis.","date":"2014","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/24481918","citation_count":24,"is_preprint":false},{"pmid":"21965736","id":"PMC_21965736","title":"Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.","date":"2011","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21965736","citation_count":24,"is_preprint":false},{"pmid":"21125336","id":"PMC_21125336","title":"Impact of uPA system gene polymorphisms on the susceptibility of environmental factors to carcinogenesis and the development of clinicopathology of oral cancer.","date":"2010","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21125336","citation_count":24,"is_preprint":false},{"pmid":"31989700","id":"PMC_31989700","title":"Curcumol may reverse early and advanced liver fibrogenesis through downregulating the uPA/uPAR pathway.","date":"2020","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/31989700","citation_count":22,"is_preprint":false},{"pmid":"29282305","id":"PMC_29282305","title":"Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29282305","citation_count":22,"is_preprint":false},{"pmid":"21540184","id":"PMC_21540184","title":"Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21540184","citation_count":22,"is_preprint":false},{"pmid":"12813583","id":"PMC_12813583","title":"The uPA/uPA receptor system as a target for tumor therapy.","date":"2001","source":"Drug news & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/12813583","citation_count":21,"is_preprint":false},{"pmid":"27650610","id":"PMC_27650610","title":"Matrine Suppresses Proliferation and Invasion of SGC7901 Cells through Inactivation of PI3K/Akt/uPA Pathway.","date":"2016","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/27650610","citation_count":21,"is_preprint":false},{"pmid":"20674898","id":"PMC_20674898","title":"Uterine luminal epithelium-specific proline-rich acidic protein 1 (PRAP1) as a marker for successful embryo implantation.","date":"2010","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/20674898","citation_count":21,"is_preprint":false},{"pmid":"17963689","id":"PMC_17963689","title":"uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17963689","citation_count":21,"is_preprint":false},{"pmid":"20578104","id":"PMC_20578104","title":"Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells.","date":"2010","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/20578104","citation_count":21,"is_preprint":false},{"pmid":"34619163","id":"PMC_34619163","title":"Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34619163","citation_count":20,"is_preprint":false},{"pmid":"23985164","id":"PMC_23985164","title":"Clinical significance of the uPA system in gastric cancer with peritoneal metastasis.","date":"2013","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/23985164","citation_count":20,"is_preprint":false},{"pmid":"21479427","id":"PMC_21479427","title":"Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479427","citation_count":20,"is_preprint":false},{"pmid":"29439245","id":"PMC_29439245","title":"Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29439245","citation_count":20,"is_preprint":false},{"pmid":"7531848","id":"PMC_7531848","title":"Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft.","date":"1995","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/7531848","citation_count":20,"is_preprint":false},{"pmid":"22314292","id":"PMC_22314292","title":"BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.","date":"2012","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22314292","citation_count":20,"is_preprint":false},{"pmid":"29720403","id":"PMC_29720403","title":"Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29720403","citation_count":19,"is_preprint":false},{"pmid":"26358253","id":"PMC_26358253","title":"BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26358253","citation_count":19,"is_preprint":false},{"pmid":"31889361","id":"PMC_31889361","title":"Epiregulin promotes trophoblast epithelial-mesenchymal transition through poFUT1 and O-fucosylation by poFUT1 on uPA.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31889361","citation_count":19,"is_preprint":false},{"pmid":"15790903","id":"PMC_15790903","title":"Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15790903","citation_count":18,"is_preprint":false},{"pmid":"31797900","id":"PMC_31797900","title":"A functional investigation of the suppression of CpG and UpA dinucleotide frequencies in plant RNA virus genomes.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31797900","citation_count":18,"is_preprint":false},{"pmid":"31601791","id":"PMC_31601791","title":"poFUT1 promotes uterine angiogenesis and vascular remodeling via enhancing the O-fucosylation on uPA.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31601791","citation_count":18,"is_preprint":false},{"pmid":"21802414","id":"PMC_21802414","title":"Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21802414","citation_count":18,"is_preprint":false},{"pmid":"24125407","id":"PMC_24125407","title":"Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis.","date":"2013","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/24125407","citation_count":18,"is_preprint":false},{"pmid":"32629119","id":"PMC_32629119","title":"Proline-Rich Acidic Protein 1 (PRAP1) Protects the Gastrointestinal Epithelium From Irradiation-Induced Apoptosis.","date":"2020","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/32629119","citation_count":17,"is_preprint":false},{"pmid":"37884951","id":"PMC_37884951","title":"circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.","date":"2023","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37884951","citation_count":17,"is_preprint":false},{"pmid":"12960238","id":"PMC_12960238","title":"The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.","date":"2003","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/12960238","citation_count":17,"is_preprint":false},{"pmid":"14667201","id":"PMC_14667201","title":"Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders.","date":"2003","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/14667201","citation_count":17,"is_preprint":false},{"pmid":"11115541","id":"PMC_11115541","title":"Regulation of the uPA gene in various grades of human glioma cells.","date":"2001","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11115541","citation_count":17,"is_preprint":false},{"pmid":"17686008","id":"PMC_17686008","title":"Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.","date":"2007","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17686008","citation_count":17,"is_preprint":false},{"pmid":"29930915","id":"PMC_29930915","title":"Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome.","date":"2018","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29930915","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52599,"output_tokens":1361,"usd":0.089106},"stage2":{"model":"claude-opus-4-6","input_tokens":4560,"output_tokens":3131,"usd":0.151613},"total_usd":0.240719,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"PRAP1 is a novel lipid-binding protein that directly binds triglyceride (TG) and facilitates MTTP-mediated lipid transfer. PRAP1 and MTTP are partially colocalized in the endoplasmic reticulum. A single amino acid mutation at position 85 (E85V) impairs PRAP1's ability to form a ternary complex with TG and MTTP, and impairs apoB-containing lipoprotein assembly and secretion, demonstrating that ternary complex formation is required for PRAP1 to facilitate MTTP-mediated lipid transport. PRAP1 is detectable in chylomicron/VLDL-rich plasma fractions, suggesting MTTP transfers TG along with PRAP1 to lipid acceptors.\",\n      \"method\": \"Co-localization (ER fractionation), in vitro lipid-binding assay, site-directed mutagenesis (E85V), lipoprotein secretion assay, PRAP1-deficient and E85V knock-in mouse models\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of ternary complex, mutagenesis, KO mouse phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"33168624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PRAP1 is a novel p53 target gene. Under DNA damage conditions (chemotherapeutic drugs, gamma irradiation, hydrogen peroxide), p53 upregulates PRAP1 expression via functional p53-response elements within intron 1 of the PRAP1 gene, which directly interact with p53 as shown by ChIP assays. PRAP1 induction promotes resistance to apoptosis by inducing cell-cycle arrest, contributing to cancer cell survival after DNA-damaging treatment.\",\n      \"method\": \"ChIP assay (p53 binding to PRAP1 intron 1), siRNA knockdown of PRAP1, cell viability and apoptosis assays after chemotherapeutic drug treatment, gamma irradiation, and hydrogen peroxide\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct p53-PRAP1 gene interaction, confirmed with KD functional readout across multiple DNA-damage stimuli\",\n      \"pmids\": [\"23235459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PRAP1 is an intrinsically disordered 17-kDa protein highly expressed in small intestinal epithelium. Prap1-/- mice show accelerated death with significantly increased apoptosis and p21 expression in the small intestinal epithelium after total body irradiation, indicating PRAP1 protects the gastrointestinal epithelium from irradiation-induced apoptosis.\",\n      \"method\": \"Prap1-/- mouse generation and challenge with total body irradiation; measurement of apoptosis and p21 expression; enteroid ex vivo irradiation model; biochemical characterization of recombinant PRAP1\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined apoptotic phenotype, supported by ex vivo enteroid model and biochemical characterization\",\n      \"pmids\": [\"32629119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PRAP1 (proline-rich acidic protein 1) mRNA is highly and specifically expressed in the uterine luminal epithelium. Its expression is regulated by progesterone (P) and estrogen (E2): P down-regulates Prap1, E2 transiently down-regulates it at 6 hours but dramatically induces it at 3 days. Prap1 expression disappears in preimplantation uterus and reappears in luminal epithelium after embryo implantation or artificial decidualization.\",\n      \"method\": \"mRNA expression analysis in ovariectomized mouse uterus with hormone treatments; temporal expression profiling across peri-implantation period\",\n      \"journal\": \"Fertility and sterility\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization and hormone-regulation experiment but functional link not directly demonstrated mechanistically\",\n      \"pmids\": [\"20674898\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRAP1 is a p53-target, intrinsically disordered protein that (1) acts as a lipid-binding co-factor in the endoplasmic reticulum, forming a ternary complex with triglyceride and MTTP to facilitate apoB-containing lipoprotein assembly and secretion; (2) is transcriptionally induced by p53 via direct binding to response elements in PRAP1 intron 1, where it promotes cell survival after DNA damage by inducing cell-cycle arrest; and (3) protects the gastrointestinal epithelial barrier from apoptosis following oxidative/radiation injury, as demonstrated by accelerated intestinal apoptosis and lethality in Prap1-/- mice.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PRAP1 is an intrinsically disordered, p53-target protein that functions both as a lipid-binding co-factor facilitating apoB-containing lipoprotein assembly and as a cytoprotective factor in gastrointestinal epithelium. In the endoplasmic reticulum, PRAP1 directly binds triglyceride and forms a ternary complex with MTTP; the E85V mutation disrupts this complex and impairs MTTP-mediated lipid transfer and lipoprotein secretion [PMID:33168624]. Under DNA damage, p53 induces PRAP1 transcription via response elements in PRAP1 intron 1, and PRAP1 promotes cell survival by inducing cell-cycle arrest rather than apoptosis; accordingly, Prap1-knockout mice exhibit accelerated intestinal epithelial apoptosis and lethality after total body irradiation [PMID:23235459, PMID:32629119].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing tissue context: PRAP1 was shown to be highly and specifically expressed in uterine luminal epithelium under hormonal regulation, placing it as an epithelium-enriched, hormonally responsive gene whose function was otherwise unknown.\",\n      \"evidence\": \"mRNA expression profiling in ovariectomized mouse uterus with progesterone and estrogen treatments\",\n      \"pmids\": [\"20674898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional consequence of PRAP1 loss or gain in the uterus was demonstrated\",\n        \"Mechanism by which steroid hormones regulate PRAP1 transcription was not defined\",\n        \"No protein-level validation of PRAP1 expression dynamics\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying the transcriptional regulator and cytoprotective role: p53 was shown to directly bind response elements in PRAP1 intron 1 and upregulate PRAP1 upon DNA damage, and PRAP1 knockdown revealed that the protein promotes cell survival by favoring cell-cycle arrest over apoptosis.\",\n      \"evidence\": \"ChIP assay for p53 occupancy at PRAP1 intron 1; siRNA knockdown with apoptosis and viability assays after chemotherapeutics, gamma irradiation, and H₂O₂ in human cancer cell lines\",\n      \"pmids\": [\"23235459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism by which PRAP1 induces cell-cycle arrest was not identified\",\n        \"In vivo relevance of the cytoprotective function was not yet tested\",\n        \"Downstream effectors or signaling pathways linking PRAP1 to arrest versus apoptosis decision were unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"In vivo validation of the cytoprotective role and structural characterization: Prap1-knockout mice demonstrated accelerated intestinal epithelial apoptosis and death after irradiation, confirming PRAP1 as a gastrointestinal barrier protector, and biochemical characterization established PRAP1 as an intrinsically disordered protein.\",\n      \"evidence\": \"Prap1-/- mouse model with total body irradiation challenge; ex vivo enteroid irradiation assay; recombinant PRAP1 biophysical characterization\",\n      \"pmids\": [\"32629119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular target or binding partner mediating the anti-apoptotic function in intestinal epithelium was not identified\",\n        \"Relationship between intrinsic disorder and function remains uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealing a second major function — lipid transport: PRAP1 was identified as a triglyceride-binding protein that forms a ternary complex with TG and MTTP in the ER, directly facilitating apoB-containing lipoprotein assembly and secretion, as proven by the E85V mutation that disrupts ternary complex formation.\",\n      \"evidence\": \"In vitro lipid-binding assays, ER co-fractionation, site-directed mutagenesis (E85V), lipoprotein secretion assays in PRAP1-deficient and E85V knock-in mice\",\n      \"pmids\": [\"33168624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how an intrinsically disordered protein binds TG and MTTP simultaneously is unknown\",\n        \"Whether the lipid-transport and cytoprotective functions are mechanistically linked is untested\",\n        \"Physiological consequences of impaired lipoprotein assembly in PRAP1-deficient mice under dietary challenge were not fully characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how PRAP1's intrinsically disordered structure enables dual functions in lipid transport and anti-apoptotic signaling, and whether these represent independent or coordinated activities in intestinal epithelium.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model explaining how PRAP1 engages both MTTP/TG and cell-cycle arrest pathways\",\n        \"Direct downstream effectors of the anti-apoptotic function have not been identified\",\n        \"Functional relevance of PRAP1 in uterine biology remains untested beyond expression data\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005357801\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MTTP\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway term_id. Let me correct:\n\n```json\n{\n  \"mechanistic_narrative\": \"PRAP1 is an intrinsically disordered, p53-target protein that functions both as a lipid-binding co-factor facilitating apoB-containing lipoprotein assembly and as a cytoprotective factor in gastrointestinal epithelium. In the endoplasmic reticulum, PRAP1 directly binds triglyceride and forms a ternary complex with MTTP; the E85V mutation disrupts this complex and impairs MTTP-mediated lipid transfer and lipoprotein secretion [PMID:33168624]. Under DNA damage, p53 induces PRAP1 transcription via response elements in PRAP1 intron 1, and PRAP1 promotes cell survival by inducing cell-cycle arrest rather than apoptosis; accordingly, Prap1-knockout mice exhibit accelerated intestinal epithelial apoptosis and lethality after total body irradiation [PMID:23235459, PMID:32629119].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing tissue context: PRAP1 was shown to be highly and specifically expressed in uterine luminal epithelium under hormonal regulation, placing it as an epithelium-enriched, hormonally responsive gene whose function was otherwise unknown.\",\n      \"evidence\": \"mRNA expression profiling in ovariectomized mouse uterus with progesterone and estrogen treatments\",\n      \"pmids\": [\"20674898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional consequence of PRAP1 loss or gain in the uterus was demonstrated\",\n        \"Mechanism by which steroid hormones regulate PRAP1 transcription was not defined\",\n        \"No protein-level validation of PRAP1 expression dynamics\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying the transcriptional regulator and cytoprotective role: p53 was shown to directly bind response elements in PRAP1 intron 1 and upregulate PRAP1 upon DNA damage, and PRAP1 knockdown revealed that the protein promotes cell survival by favoring cell-cycle arrest over apoptosis.\",\n      \"evidence\": \"ChIP assay for p53 occupancy at PRAP1 intron 1; siRNA knockdown with apoptosis and viability assays after chemotherapeutics, gamma irradiation, and H2O2 in human cancer cell lines\",\n      \"pmids\": [\"23235459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism by which PRAP1 induces cell-cycle arrest was not identified\",\n        \"In vivo relevance of the cytoprotective function was not yet tested\",\n        \"Downstream effectors linking PRAP1 to the arrest-versus-apoptosis decision were unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"In vivo validation of the cytoprotective role: Prap1-knockout mice demonstrated accelerated intestinal epithelial apoptosis and death after irradiation, confirming PRAP1 as a gastrointestinal barrier protector, and biochemical characterization established PRAP1 as an intrinsically disordered protein.\",\n      \"evidence\": \"Prap1-/- mouse model with total body irradiation challenge; ex vivo enteroid irradiation assay; recombinant PRAP1 biophysical characterization\",\n      \"pmids\": [\"32629119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular target mediating the anti-apoptotic function in intestinal epithelium was not identified\",\n        \"Relationship between intrinsic disorder and function remains uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealing a second major function in lipid transport: PRAP1 was identified as a triglyceride-binding protein that forms a ternary complex with TG and MTTP in the ER, directly facilitating apoB-containing lipoprotein assembly and secretion, as proven by the E85V mutation that disrupts ternary complex formation.\",\n      \"evidence\": \"In vitro lipid-binding assays, ER co-fractionation, site-directed mutagenesis (E85V), lipoprotein secretion assays in PRAP1-deficient and E85V knock-in mice\",\n      \"pmids\": [\"33168624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how an intrinsically disordered protein binds TG and MTTP simultaneously is unknown\",\n        \"Whether the lipid-transport and cytoprotective functions are mechanistically linked is untested\",\n        \"Physiological consequences under dietary lipid challenge were not fully characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how PRAP1's intrinsically disordered structure enables dual functions in lipid transport and anti-apoptotic signaling, and whether these represent independent or coordinated activities in intestinal epithelium.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model explaining how PRAP1 engages both MTTP/TG and cell-cycle arrest pathways\",\n        \"Direct downstream effectors of the anti-apoptotic function have not been identified\",\n        \"Functional relevance of PRAP1 in uterine biology remains untested beyond expression data\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MTTP\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}